Atypical Reactive Lymphocytes on Morphology: Clinical Significance
Atypical reactive lymphocytes on morphological review typically indicate an active immune response to infection, inflammation, or antigenic stimulation, and are generally associated with benign processes rather than malignancy—though they require careful correlation with clinical context and may warrant flow cytometry to exclude lymphoproliferative disorders.
What They Represent
Atypical reactive lymphocytes are morphologically abnormal lymphocytes that appear in peripheral blood during immune activation. These cells characteristically show:
- Larger size with abundant cytoplasm
- Irregular nuclear contours (hyperconvoluted or cerebriform nuclei in some cases)
- Basophilic cytoplasm
- Variable nuclear-to-cytoplasmic ratios
- May include prolymphocytes or lymphoplasmacytoid forms 1, 2, 3
The key distinction is that these cells represent activated, non-malignant lymphocytes responding to stimulation, not neoplastic transformation.
Common Clinical Contexts
Atypical reactive lymphocytes appear in several settings:
Viral Infections
- Infectious mononucleosis (EBV) is the classic cause 4
- COVID-19 infection—where their presence actually correlates with better prognosis and survival 5
- Other viral infections (CMV, HIV, viral hepatitis)
Other Reactive Conditions
- Autoimmune disorders
- Drug reactions
- Post-vaccination responses
- Severe bacterial infections 5
Critical Diagnostic Pitfall: Not Specific for Malignancy
A major pitfall is assuming atypical morphology equals malignancy. The evidence clearly shows:
- Atypical lymphocytes are not specific for lymphoproliferative disorders and can be seen in healthy individuals and benign conditions 6
- Morphological assessment alone has high interobserver variability and is subjective 6, 7
- "Reactive" morphology is highly predictive of benign process (negative predictive value 0.58), but "malignant" morphology is a poor predictor of actual lymphoproliferative disorder 8
When to Suspect Malignancy vs. Reactive Process
Features Suggesting Reactive Process:
- Younger age
- Lower absolute lymphocyte count (typically <7×10⁹/L) 8
- Clinical context of acute infection
- Transient nature
- In COVID-19: presence correlates with better outcomes, higher hemoglobin, and lower mortality 5
Features Raising Concern for Lymphoproliferative Disorder:
- Persistent lymphocytosis (≥5×10⁹/L for CLL diagnosis) 1, 2, 3
- Advanced age 8
- Higher absolute lymphocyte count (>7×10⁹/L warrants closer scrutiny) 8
- >10% prolymphocytes or >15% cleaved/lymphoplasmacytoid cells in CLL patients indicates adverse prognosis 9
- Absence of infectious symptoms
- Associated lymphadenopathy, splenomegaly, or cytopenias 2
Recommended Diagnostic Approach
When atypical reactive lymphocytes are identified on morphology:
Correlate with clinical presentation: Look specifically for fever, pharyngitis, rash, recent vaccination, known infections, or immunosuppression
Review absolute lymphocyte count:
Flow cytometry is essential when:
Flow cytometry provides objective assessment:
For suspected infectious mononucleosis with negative heterophile test: Obtain EBV serologies (VCA-IgM, VCA-IgG, EBNA) as up to 10% of IM cases are heterophile-negative 4
Prognostic Implications
In established CLL: Atypical lymphocyte morphology (>10% prolymphocytes or >15% cleaved/lymphoplasmacytoid cells) is an independent adverse prognostic factor for disease progression, even more significant than trisomy 12 9.
In COVID-19: Presence of atypical reactive lymphocytes indicates robust T-cell response and correlates with better survival and clinical outcomes 5.
Key Takeaway
Morphology alone cannot reliably distinguish reactive from malignant lymphocytes 6, 8, 7. The finding of atypical reactive lymphocytes should prompt clinical correlation and, when lymphocytosis is persistent (>4 weeks) or absolute count is elevated (≥5-7×10⁹/L), flow cytometry is mandatory to definitively exclude lymphoproliferative disorders 1, 10, 2, 11.